Niki BioSolutions, Inc. (NIKI) FCF Margin (2017 - 2025)
Niki BioSolutions' (NIKI) quarterly FCF Margin came in at 27.41% in Q4 2025, up 6387.0% YoY from 0.42% in Q4 2024, and up 148.07% on a QoQ basis from 57.01% in Q3 2025.
Niki BioSolutions, Inc. (NIKI) FCF Margin (2017 - 2025) Analysis & Trends
Niki BioSolutions (NIKI) has 3 years of FCF Margin data on file, last reported at 27.41% in Q4 2025.
- Quarterly FCF Margin rose 6387.0% year-over-year to 27.41% in Q4 2025, while the trailing twelve-month figure through Nov 2025 was 51.19% (changed N/A YoY) and the FY2025 annual result came in at 49.62%, down 2630.0% from the prior year.
- FCF Margin grew to 27.41% in Q4 2025, from 57.01% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 27.41% in Q4 2025 to a low of 57.01% in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | 27.41% |
| Aug 31, 2025 | -57.01% |
| Nov 30, 2024 | -36.46% |
| Aug 31, 2024 | -28.99% |
| Dec 31, 2017 | 1,530.74% |